Recombinant multi-species ASXL2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ASXL2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of a family of epigenetic regulators that bind various histone-modifying enzymes and are involved in the assembly of transcription factors at specific genomic loci. Naturally occurring mutations in this gene are associated with cancer in several tissue types (breast, bladder, pancreas, ovary, prostate, and blood). This gene plays an important role in neurodevelopment, cardiac function, adipogenesis, and osteoclastogenesis. [provided by RefSeq, Feb 2017]
The Alternative Names of target: 4930556B16Rik,ASXH2,ASXL2,Additional sex combs-like protein 2,Asxl2,Putative Polycomb group protein ASXL2,SHAPNS,mKIAA1685
Go
to ASXL2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP10077-Ag-1/ GM-Tg-hg-IP10077-Ag-2 | Human ASXL2 protein | Human |
| GM-Tg-rg-IP10077-Ag-1/ GM-Tg-rg-IP10077-Ag-2 | Rat ASXL2 protein | Rat |
| GM-Tg-mg-IP10077-Ag-1/ GM-Tg-mg-IP10077-Ag-2 | Mouse ASXL2 protein | Mouse |
| GM-Tg-cynog-IP10077-Ag-1/ GM-Tg-cynog-IP10077-Ag-2 | Cynomolgus/Rhesus macaque ASXL2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP10077-Ag-1/ GM-Tg-felg-IP10077-Ag-2 | Feline ASXL2 protein | Feline |
| GM-Tg-cang-IP10077-Ag-1/ GM-Tg-cang-IP10077-Ag-2 | Canine ASXL2 protein | Canine |
| GM-Tg-bovg-IP10077-Ag-1/ GM-Tg-bovg-IP10077-Ag-2 | Bovine ASXL2 protein | Bovine |
| GM-Tg-equg-IP10077-Ag-1/ GM-Tg-equg-IP10077-Ag-2 | Equine ASXL2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP10077-Ag-1/ GM-Tg-hg-IP10077-Ag-2;
GM-Tg-rg-IP10077-Ag-1/ GM-Tg-rg-IP10077-Ag-2;
GM-Tg-mg-IP10077-Ag-1/ GM-Tg-mg-IP10077-Ag-2; GM-Tg-cynog-IP10077-Ag-1/ GM-Tg-cynog-IP10077-Ag-2; GM-Tg-felg-IP10077-Ag-1/ GM-Tg-felg-IP10077-Ag-2; GM-Tg-cang-IP10077-Ag-1/ GM-Tg-cang-IP10077-Ag-2; GM-Tg-bovg-IP10077-Ag-1/ GM-Tg-bovg-IP10077-Ag-2; GM-Tg-equg-IP10077-Ag-1/ GM-Tg-equg-IP10077-Ag-2 |
| Products Name | ASXL2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | ASXL2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ASXL2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.